Methods of use of soluble CD24 for treating lupus nephritis Grant US-11571461-B2 United States of America 07 Feb 2023
METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS Application EP-3845238-A1 European Patent Office 07 Jul 2021
METHODS OF USE OF SOLUBLE CD24 FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS Application EP-3592375-A4 European Patent Office 20 Jan 2021
METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS Application EP-3260128-A1 European Patent Office 27 Dec 2017